Skip to content

SOMEDIC

Active
Private limited companyfounded 20214 yrs activePlace de l'Eglise 19, 6680 Sainte-Ode, BelgiumKBO/BCE: BE 0779.284.637
Summary

SOMEDIC has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €327,394 and a net result of €114,277. Equity is growing by ~45.1% per year across the filed fiscal years. Its solvency ranks better than 86% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 22.79 against 9.67 in 2023; short-term debt: 4.2% and cash: 71.4% of total assets), and 7.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 4 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
92.4%
Return on assets
32.3%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
35 d early
2024
21 d early
2023
29 d early
2022
6 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 7 July (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

SOMEDIC was incorporated on 23 December 2021 as a Private limited company.1 Total assets rose from EUR 186,199 in 2022 to EUR 354,341 in 2024 and headcount from 2 to 2.5 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2022 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€327,394▲ 53.6%
2023 · €213,118
Total assets
€354,341▲ 46.7%
2023 · €241,526
Net result
€114,277▲ 46.6%
2023 · €77,936
Working capital
€325,744▲ 64.5%
2023 · €198,074
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line202220232024
Operating result€104,873-€110,263▲ 5.1%€162,654▲ 47.5%
Net result€74,082within the sector's middle half-€77,936within the sector's middle half▲ 5.2%€114,277within the sector's middle half▲ 46.6%
Equity€135,182within the sector's middle half-€213,118within the sector's middle half▲ 57.7%€327,394within the sector's middle half▲ 53.6%
Total assets€186,199within the sector's middle half-€241,526within the sector's middle half▲ 29.7%€354,341within the sector's middle half▲ 46.7%
Debt€51,017-€28,409▼ 44.3%€26,947▼ 5.1%
Working capital€119,580within the sector's middle half-€198,074within the sector's middle half▲ 65.6%€325,744above the sector's middle half▲ 64.5%
Solvency72.6%within the sector's middle half-88.2%above the sector's middle half▲ 15.6pp92.4%above the sector's middle half▲ 4.2pp
Current ratio4.07within the sector's middle half-9.67above the sector's middle half▲ 5.6022.79above the sector's middle half▲ 13.12
Return on assets (ROA)39.8%above the sector's middle half-32.3%within the sector's middle half▼ 7.5pp32.3%within the sector's middle half=
Staff (FTE)2-2.3▲ 15.0%2.5▲ 8.7%
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000€150,000Operating result 2022: €104,873€104,873Net result 2022: €74,082€74,082Operating result 2023: €110,263€110,263Net result 2023: €77,936€77,936Operating result 2024: €162,654€162,654Net result 2024: €114,277€114,277202220232024€0€50,000€100,000€150,000Operating result 2022: €104,873€105,000Net result 2022: €74,082€74,100Operating result 2023: €110,263€110,000Net result 2023: €77,936€77,900Operating result 2024: €162,654€163,000Net result 2024: €114,277€114,000202220232024
The operating result has risen two years in a row; 2024 is 48% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €354,341
Fixed assets €13,650 ▼ 33.8%
Current assets €340,691 ▲ 54.2%
Equity and liabilities €354,341
Equity €327,394 ▲ 53.6%
Debt €26,947 ▼ 5.1%
Debt's share of the balance-sheet total falls from 11.8% to 7.6%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€174,609▲
2023 · €121,676
Cash flow
€126,232▲
2023 · €89,348
Debt to equity
0.08▼
2023 · 0.13
ROE
34.9%▼
2023 · 36.6%
Interest coverage
350.15▲
2023 · 165.78
Debt ≤ 1 year
€14,947▼
2023 · €22,841
Income taxes
€48,115▲
2023 · €31,812
Staff costs
€49,458▼
2023 · €50,163
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 47 lines
Balance sheet Code20232024
Assets
Total assets20/58€241,526€354,341▲
Fixed assets21/28€20,611€13,650▼
Intangible fixed assets21€551-
Tangible fixed assets22/27€15,060€8,650▼
Plant, machinery and equipment23€2,161€1,340▼
Furniture and vehicles24€10,646€7,310▼
Other tangible fixed assets26€2,253-
Financial fixed assets28€5,000€5,000=
Current assets29/58€220,915€340,691▲
Amounts receivable within one year40/41€51,865€80,056▲
Other amounts receivable41€51,865€80,056▲
Current investments50/53€2,266€2,266=
Cash at bank and in hand54/58€161,156€252,921▲
Deferred charges and accrued income490/1€5,628€5,447▼
Equity and liabilities
Total equity and liabilities10/49€241,526€354,341▲
Equity10/15€213,118€327,394▲
Contributions10/11€61,100€61,100=
Reserves13€152,018€266,294▲
Distributable reserves133€152,018€266,294▲
Amounts payable17/49€28,409€26,947▼
Amounts payable after more than one year17€932-
Financial debts170/4€932-
Amounts payable within one year42/48€22,841€14,947▼
Current portion of amounts payable after more than one year42€5,566€932▼
Trade debts44€4,949€6,898▲
Suppliers440/4€4,949€6,898▲
Taxes, remuneration and social security45€12,179€3,841▼
Taxes450/3€1,812-
Remuneration and social security454/9€10,367€3,841▼
Other amounts payable47/48€147€3,276▲
Accrued charges and deferred income492/3€4,635€12,000▲
Income statement Code20232024
Remuneration, social security and pensions62€50,163€49,458▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11,412€11,955▲
Other operating charges640/8€909€1,250▲
Gross operating margin9900€172,748€225,317▲
Operating profit (loss)9901€110,263€162,654▲
Financial income75/76B€219€237▲
Recurring financial income75€219€237▲
Financial charges65/66B€734€499▼
Recurring financial charges65€734€499▼
Profit (loss) for the period before taxes9903€109,748€162,392▲
Income taxes67/77€31,812€48,115▲
Profit (loss) for the period9904€77,936€114,277▲
Profit (loss) for the period to be appropriated9905€77,936€114,277▲
Appropriation of the result
Profit (loss) to be appropriated9906€77,936€114,277▲
Transfer to equity691/2€77,936€114,277▲
To other reserves6921€77,936€114,277▲

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202220232024Change
Remuneration, social security and pensions62€82,766€50,163€49,458▼ 1.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,259€11,412€11,955▲ 4.8%
Other operating charges640/8€2,384€909€1,250▲ 37.5%
Gross operating margin9900€203,282€172,748€225,317▲ 30.4%
Operating profit (loss)9901€104,873€110,263€162,654▲ 47.5%
Financial income75/76B€309€219€237▲ 8.2%
Recurring financial income75€309€219€237▲ 8.2%
Financial charges65/66B€1,297€734€499▼ 32.1%
Recurring financial charges65€1,297€734€499▼ 32.1%
Profit (loss) for the period before taxes9903€103,886€109,748€162,392▲ 48.0%
Income taxes67/77€29,804€31,812€48,115▲ 51.2%
Profit (loss) for the period9904€74,082€77,936€114,277▲ 46.6%
Profit (loss) for the period to be appropriated9905€74,082€77,936€114,277▲ 46.6%
Line202220232024Change
Assets
Total assets20/58€186,199€241,526€354,341▲ 46.7%
Fixed assets21/28€27,685€20,611€13,650▼ 33.8%
Intangible fixed assets21€1,103€551--
Tangible fixed assets22/27€21,582€15,060€8,650▼ 42.6%
Plant, machinery and equipment23€3,248€2,161€1,340▼ 38.0%
Furniture and vehicles24€13,828€10,646€7,310▼ 31.3%
Other tangible fixed assets26€4,506€2,253--
Financial fixed assets28€5,000€5,000€5,000=
Current assets29/58€158,514€220,915€340,691▲ 54.2%
Amounts receivable within one year40/41€51,367€51,865€80,056▲ 54.4%
Other amounts receivable41€51,367€51,865€80,056▲ 54.4%
Current investments50/53€2,266€2,266€2,266=
Cash at bank and in hand54/58€101,351€161,156€252,921▲ 56.9%
Deferred charges and accrued income490/1€3,529€5,628€5,447▼ 3.2%
Equity and liabilities
Total equity and liabilities10/49€186,199€241,526€354,341▲ 46.7%
Equity10/15€135,182€213,118€327,394▲ 53.6%
Contributions10/11€61,100€61,100€61,100=
Reserves13€74,082€152,018€266,294▲ 75.2%
Distributable reserves133€74,082€152,018€266,294▲ 75.2%
Amounts payable17/49€51,017€28,409€26,947▼ 5.1%
Amounts payable after more than one year17€6,499€932--
Financial debts170/4€6,499€932--
Amounts payable within one year42/48€38,934€22,841€14,947▼ 34.6%
Current portion of amounts payable after more than one year42€5,516€5,566€932▼ 83.2%
Trade debts44€5,274€4,949€6,898▲ 39.4%
Suppliers440/4€5,274€4,949€6,898▲ 39.4%
Taxes, remuneration and social security45€19,941€12,179€3,841▼ 68.5%
Taxes450/3€10,497€1,812--
Remuneration and social security454/9€9,444€10,367€3,841▼ 63.0%
Other amounts payable47/48€8,203€147€3,276▲ 2,133%
Accrued charges and deferred income492/3€5,584€4,635€12,000▲ 159%
Line202220232024Change
Profit (loss) for the period9904€74,082€77,936€114,277▲ 46.6%
+ Depreciation and write-downs630€13,259€11,412€11,955▲ 4.8%
Operating cash flow (approximation)€87,341€89,348€126,232▲ 41.3%
Investment in fixed assets (approximation)--€4,338-€4,994▼ 15.1%
Change in cash-€59,805€91,765▲ 53.4%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
10-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2022net €114,277 ▲46.6%
Operating result €162,654, net result €114,277, both a record.
31-12
Financial Liquidity doublescurrent ratio 22.79
Current ratio from 9.67 to 22.79; short-term debt falls from €22,841 to €14,947.
02-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Liquidity doublescurrent ratio 9.67
Current ratio from 4.07 to 9.67; short-term debt falls from €38,934 to €22,841.
31-12
Financial Equity above €200,000Eq €213,118 ▲57.7%
2 profitable years in a row build equity to €213,118.
25-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sainte-Ode · 1 establishment unit since 2021
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Place de l'Eglise 196680 Sainte-Ode
1 establishment unit
Place de l'Eglise 19, 6680 Sainte-Ode
General medical practice
since 20212.329.216.161

Similar companies · same sector, comparable size

Of 9,130 companies in sector 86210 we hold annual accounts for 6,336. 5,184 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded23-12-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.